Bright Minds Biosciences Stock Quote DRUG - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.25

Bid

1.19

Ask

1.35

Volume

0.00 Day's Range 0.00

0.93 52 Week Range 2.39

Market Cap

5.58M

Previous Close

1.25

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

116,199

Shares Outstanding

4,463,837

Dividend Yield

PE Ratio

-0.76

Earnings Per Share (EPS)

-1.65

Revenue

Net Profit

-7.37M

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disord... Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.brightmindsbio.com

Headquarters

Vancouver, British Columbia, Can

Founded

Bright Minds Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRUG. The last closing price for Bright Minds Biosciences was $1.25. Over the last year, Bright Minds Biosciences shares have traded in a share price range of $ 0.93 to $ 2.39.

Bright Minds Biosciences currently has 4,463,837 shares outstanding. The market capitalization of Bright Minds Biosciences is $5.58 million. Bright Minds Biosciences has a price to earnings ratio (PE ratio) of -0.76.

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy Canada NewsWire NEW YORK, Sept. 12, 2024...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	1.62601626016	1.23	1.4	1.1501	29684	1.25702027	CS
4	0.22	21.359223301	1.03	1.75	0.99	290654	1.32957973	CS
12	0.17	15.7407407407	1.08	1.75	0.9305	116199	1.296239	CS
26	-0.01	-0.793650793651	1.26	1.75	0.93	61511	1.27738154	CS
52	-0.4	-24.2424242424	1.65	2.39	0.93	44635	1.3990256	CS
156	-43.5	-97.2067039106	44.75	44.75	0.93	1296683	10.29073674	CS
260	-43.5	-97.2067039106	44.75	44.75	0.93	1296683	10.29073674	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1224 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.9381 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.87 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.5187 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1224 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.9381 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.87 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.5187 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1224 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 62.9381 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.87 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.5187 (0.00%)	0